mTOR inhibition in autosomal-dominant polycystic kidney disease (ADPKD): the question remains open
- PMID: 23222536
- DOI: 10.1093/ndt/gfs519
mTOR inhibition in autosomal-dominant polycystic kidney disease (ADPKD): the question remains open
Comment on
-
Rapamycin for treatment of type I autosomal dominant polycystic kidney disease (RAPYD-study): a randomized, controlled study.Nephrol Dial Transplant. 2012 Sep;27(9):3560-7. doi: 10.1093/ndt/gfs264. Epub 2012 Jul 10. Nephrol Dial Transplant. 2012. PMID: 22785114 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
